Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Hematology/Oncology ClinicsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Phase II study of a radiotherapy total dose increase in hypoxic lesions identified by (18)F-Misonidazole PET/CT in patients with non-small cell lung carcinoma (RTEP5 study).J Nucl Med. 2017; 58: 1045-1053
- Prospective in silico study of the feasibility and dosimetric advantages of MRI-guided dose adaptation for human papillomavirus positive oropharyngeal cancer patients compared with standard IMRT.Clin Transl Radiat Oncol. 2018; 11: 11-18
- Can radiomics features be reproducibly measured from CBCT images for patients with non-small cell lung cancer?.Med Phys. 2015; 42: 6784-6797
- New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).Eur J Cancer. 2009; 45: 228-247
- Functional imaging for radiotherapy treatment planning: current status and future directions—a review.Br J Radiol. 2015; 88: 20150056
- Dynamic contrast-enhanced imaging techniques: CT and MRI.Br J Radiol. 2011; 84: S112-S120
- Automated voxel-based analysis of volumetric dynamic contrast-enhanced CT data improves measurement of serial changes in tumor vascular biomarkers.Int J Radiat Oncol Biol Phys. 2015; 91: 48-57
- Liver function after irradiation based on computed tomographic portal vein perfusion imaging.Int J Radiat Oncol Biol Phys. 2008; 70: 154-160
- Clustering of multi-parametric functional imaging to identify high-risk subvolumes in non-small cell lung cancer.Radiother Oncol. 2017; 125: 379-384
- Radiochemotherapy-induced changes of tumour vascularity and blood supply estimated by dynamic contrast-enhanced CT and fractal analysis in malignant head and neck tumours.Br J Radiol. 2015; 88: 20140412
- Dynamic contrast-enhanced CT to assess metabolic response in patients with advanced non-small cell lung cancer and stable disease after chemotherapy or chemoradiotherapy.Eur Radiol. 2013; 23: 1573-1581
- Quantitative imaging biomarkers alliance (QIBA) recommendations for improved precision of DWI and DCE-MRI derived biomarkers in multicenter oncology trials.J Magn Reson Imaging. 2019; 49: e101-e121
- Dual energy CT in radiotherapy: current applications and future outlook.Radiother Oncol. 2016; 119: 137-144
- Dual energy CT in practice: basic principles and applications.Appl Radiol. 2016; 45: 6-12
- Oncologic applications of dual-energy CT in the abdomen.Radiographics. 2014; 34: 589-612
- Dual-energy computed tomography for prediction of loco-regional recurrence after radiotherapy in larynx and hypopharynx squamous cell carcinoma.Eur J Radiol. 2019; 110: 1-6
- Comparison of dual-energy CT-derived iodine content and iodine overlay of normal, inflammatory and metastatic squamous cell carcinoma cervical lymph nodes.Eur Radiol. 2014; 24: 574-580
- Assessing lung function using contrast-enhanced dual-energy computed tomography for potential applications in radiation therapy.Med Phys. 2017; 44: 5260-5269
- Radiomics: extracting more information from medical images using advanced feature analysis.Eur J Cancer. 2012; 48: 441-446
- The applications of radiomics in precision diagnosis and treatment of oncology: opportunities and challenges.Theranostics. 2019; 9: 1303-1322
- A radiomic approach for adaptive radiotherapy in non-small cell lung cancer patients.PLoS One. 2018; 13: e0207455
Sicilia R, Cordelli E, Ramella S, et al. Exploratory radiomics for predicting adaptive radiotherapy in non-small cell lung cancer. Paper presented at: 2018 IEEE 31st International Symposium on Computer-Based Medical Systems (CBMS). Karlstad University, June 18–21, 2018.
- Early assessment of treatment responses during radiation therapy for lung cancer using quantitative analysis of daily computed tomography.Int J Radiat Oncol Biol Phys. 2017; 98: 463-472
- PO-0991: serial tumor radiomic features predict response of head and neck cancer treated with radiotherapy.Radiother Oncol. 2018; 127: S551
- Response criteria for phase II studies of supratentorial malignant glioma.J Clin Oncol. 1990; 8: 1277-1280
- Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group.J Clin Oncol. 2010; 28: 1963-1972
- Diagnostic accuracy of magnetic resonance imaging techniques for treatment response evaluation in patients with high-grade glioma, a systematic review and meta-analysis.Eur Radiol. 2017; 27: 4129-4144
- Immunotherapy response assessment in neuro-oncology: a report of the RANO working group.Lancet Oncol. 2015; 16: e534-e542
- Relative cerebral blood volume values to differentiate high-grade glioma recurrence from posttreatment radiation effect: direct correlation between image-guided tissue histopathology and localized dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging measurements.AJNR Am J Neuroradiol. 2009; 30: 552-558
- Support vector machine multiparametric MRI identification of pseudoprogression from tumor recurrence in patients with resected glioblastoma.J Magn Reson Imaging. 2011; 33: 296-305
- Differentiation of tumor progression from pseudoprogression in patients with posttreatment glioblastoma using multiparametric histogram analysis.AJNR Am J Neuroradiol. 2014; 35: 1309-1317
- Differentiation of cerebral radiation necrosis from tumor recurrence by proton magnetic resonance spectroscopy.Neurol Med Chir (Tokyo). 1997; 37: 250-256
- Advanced MRI increases the diagnostic accuracy of recurrent glioblastoma: single institution thresholds and validation of MR spectroscopy and diffusion weighted MR imaging.Neuroimage Clin. 2016; 11: 316-321
- Diagnosis and treatment of progressive space-occupying radiation necrosis following stereotactic radiosurgery for brain metastasis: value of proton magnetic resonance spectroscopy.Acta Neurochir (Wien). 2003; 145 ([discussion: 564]): 557-564
- Diffusion-weighted magnetic resonance imaging for predicting and detecting early response to chemoradiation therapy of squamous cell carcinomas of the head and neck.Clin Cancer Res. 2009; 15: 986-994
- Predictive value of pre-treatment apparent diffusion coefficient (ADC) in radio-chemotherapy treated head and neck squamous cell carcinoma.Radiol Med. 2017; 122: 345-352
- Clinical utility of multimodality imaging with dynamic contrast-enhanced MRI, diffusion-weighted MRI, and 18F-FDG PET/CT for the prediction of neck control in oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiation.PLoS One. 2014; 9: e115933
- Dynamic contrast-enhanced MR imaging predicts local control in oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiotherapy.PLoS One. 2013; 8: e72230
- Prediction of response to chemoradiation therapy in squamous cell carcinomas of the head and neck using dynamic contrast-enhanced MR imaging.AJNR Am J Neuroradiol. 2010; 31: 262-268
- Biomedical imaging: principles, technologies, clinical aspects, contrast agents, limitations and future trends in nanomedicines.Pharm Res. 2019; 36: 78
- The physics of functional magnetic resonance imaging (fMRI).Rep Prog Phys. 2013; 76: 096601
- Beyond imaging: the promise of radiomics.Phys Med. 2017; 38: 122-139
- Radiomics of multiparametric MRI for pretreatment prediction of pathologic complete response to neoadjuvant chemotherapy in breast cancer: a multicenter study.Clin Cancer Res. 2019; 25: 3538-3547
- Multiparametric MRI-based radiomics analysis for prediction of breast cancers insensitive to neoadjuvant chemotherapy.Clin Transl Oncol. 2019; ([Epub ahead of print])
- Pretreatment MRI radiomics analysis allows for reliable prediction of local recurrence in non-metastatic T4 nasopharyngeal carcinoma.EBioMedicine. 2019; 42: 270-280
- Radiomics on multi-modalities MR sequences can subtype patients with non-metastatic nasopharyngeal carcinoma (NPC) into distinct survival subgroups.Eur Radiol. 2019; 29: 5590-5599
- Gray-level discretization impacts reproducible MRI radiomics texture features.PLoS One. 2019; 14: e0213459
- Reproducibility of radiomics for deciphering tumor phenotype with imaging.Sci Rep. 2016; 6: 23428
- 18F-FDG PET and PET/CT in the evaluation of cancer treatment response.J Nucl Med. 2009; 50: 88-99
- Value of FDG PET in assessment of treatment response and surveillance in head-and-neck cancer patients after intensity modulated radiation treatment: a preliminary report.Int J Radiat Oncol Biol Phys. 2004; 60: 1410-1418
- PET-CT for response assessment and treatment adaptation in head and neck cancer.Lancet Oncol. 2010; 11: 661-669
- Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group.Eur J Cancer. 1999; 35: 1773-1782
- From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors.J Nucl Med. 2009; 50: 122S-150S
- Comparison of the EORTC criteria and PERCIST in solid tumors: a pooled analysis and review.Oncotarget. 2016; 7: 58105-58110
- Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification.J Clin Oncol. 2014; 32: 3059-3068
- Visualizing cancer and immune cell function with metabolic positron emission tomography.Curr Opin Genet Dev. 2010; 20: 100-105
- Delayed response assessment with FDG-PET-CT following (chemo) radiotherapy for locally advanced head and neck squamous cell carcinoma.Clin Radiol. 2012; 67: 966-975
- Monitoring tumor response to therapy with 18F-FLT PET.J Nucl Med. 2010; 51: 841-844
- The Warburg effect: how does it benefit cancer cells?.Trends Biochem Sci. 2016; 41: 211-218
- Targeting hypoxia in cancer therapy.Nat Rev Cancer. 2011; 11: 393-410
- Tumor hypoxia imaging.Mol Imaging Biol. 2011; 13: 399-410
- PET radiopharmaceuticals for imaging of tumor hypoxia: a review of the evidence.Am J Nucl Med Mol Imaging. 2014; 4: 365-384
- Longitudinal PET imaging of tumor hypoxia during the course of radiotherapy.Eur J Nucl Med Mol Imaging. 2018; 45: 2201-2217
- Selection of patients for radiotherapy with protons aiming at reduction of side effects: the model-based approach.Radiother Oncol. 2013; 107: 267-273
- Intensity modulation methods for proton radiotherapy.Phys Med Biol. 1999; 44: 185-205
- The future of image-guided radiotherapy will be MR guided.Br J Radiol. 2017; 90: 20160667
- Geometric image biomarker changes of the parotid gland are associated with late xerostomia.Int J Radiat Oncol Biol Phys. 2017; 99: 1101-1110
- A two-variable linear model of parotid shrinkage during IMRT for head and neck cancer.Radiother Oncol. 2010; 94: 206-212
- Early prediction of acute xerostomia during radiation therapy for head and neck cancer based on texture analysis of daily CT.Int J Radiat Oncol Biol Phys. 2018; 102: 1308-1318
- Lung texture in serial thoracic computed tomography scans: correlation of radiomics-based features with radiation therapy dose and radiation pneumonitis development.Int J Radiat Oncol Biol Phys. 2015; 91: 1048-1056
- Radiomics: images are more than pictures, they are data.Radiology. 2016; 278: 563-577
- Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach.Nat Commun. 2014; 5: 4006
- CT image biomarkers to improve patient-specific prediction of radiation-induced xerostomia and sticky saliva.Radiother Oncol. 2017; 122: 185-191
- Early changes in serial CBCT-measured parotid gland biomarkers predict chronic xerostomia after head and neck radiation therapy.Int J Radiat Oncol Biol Phys. 2018; 102: 1319-1329
- Radiomics to predict immunotherapy-induced pneumonitis: proof of concept.Invest New Drugs. 2018; 36: 601-607
- Repetitive MRI of organs at risk in head and neck cancer patients undergoing radiotherapy.Clin Transl Radiat Oncol. 2019; 18: 131-139
- Anatomical changes in the pharyngeal constrictors after chemo-irradiation of head and neck cancer and their dose-effect relationships: MRI-based study.Radiother Oncol. 2009; 93: 510-515
- Evaluation of salivary gland function using diffusion-weighted magnetic resonance imaging for follow-up of radiation-induced xerostomia.Korean J Radiol. 2018; 19: 758-766
- Early evaluation of radiation-induced parotid damage in patients with nasopharyngeal carcinoma by T2 mapping and mDIXON Quant imaging: initial findings.Radiat Oncol. 2018; 13: 22
- Differences in delineation guidelines for head and neck cancer result in inconsistent reported dose and corresponding NTCP.Radiother Oncol. 2014; 111: 148-152
- Impact of post-processing methods on apparent diffusion coefficient values.Eur Radiol. 2017; 27: 946-955
- Parotid gland fat related Magnetic Resonance image biomarkers improve prediction of late radiation-induced xerostomia.Radiother Oncol. 2018; 128: 459-466
- Magnetic resonance imaging radiomic feature analysis of radiation-induced femoral head changes in prostate cancer radiotherapy.J Cancer Res Ther. 2019; 15: S11-S19
- Principles of PET/CT.in: Kim E.E. Lee M.C. Inoue R. Clinical PET. Springer, 2004 (ISBN 9781441923554. p. 41-61)
- Time and dose-related changes in lung perfusion after definitive radiotherapy for NSCLC.Radiother Oncol. 2018; 126: 307-311
- Metabolic imaging biomarkers of postradiotherapy xerostomia.Int J Radiat Oncol Biol Phys. 2012; 83: 1609-1616
- Physiologic distribution of PSMA-ligand in salivary glands and seromucous glands of the head and neck on PET/CT.Oral Surg Oral Med Oral Pathol Oral Radiol. 2018; 125: 478-486
- [(1)(8)F]fluorodeoxyglucose uptake patterns in lung before radiotherapy identify areas more susceptible to radiation-induced lung toxicity in non-small-cell lung cancer patients.Int J Radiat Oncol Biol Phys. 2011; 81: 698-705
- (15)O-H2O PET/CT as a tool for the quantitative assessment of early post-radiotherapy changes of heart perfusion in breast carcinoma patients.Br J Radiol. 2018; 91: 20170653
- 18F-FDG PET/CT findings of radiotherapy-related myocardial changes in patients with thoracic malignancies.Nucl Med Commun. 2013; 34: 855-859
Article info
Publication history
Published online: October 30, 2019
Footnotes
Disclosure Statement: See last page of article.
Identification
Copyright
© 2019 Elsevier Inc. All rights reserved.
